238 related articles for article (PubMed ID: 8173365)
1. Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial.
Maltby N; Broe GA; Creasey H; Jorm AF; Christensen H; Brooks WS
BMJ; 1994 Apr; 308(6933):879-83. PubMed ID: 8173365
[TBL] [Abstract][Full Text] [Related]
2. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.
Chatellier G; Lacomblez L
BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926
[TBL] [Abstract][Full Text] [Related]
3. Tacrine in Alzheimer's disease.
Eagger SA; Levy R; Sahakian BJ
Lancet; 1991 Apr; 337(8748):989-92. PubMed ID: 1673209
[TBL] [Abstract][Full Text] [Related]
4. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
Davis KL; Thal LJ; Gamzu ER; Davis CS; Woolson RF; Gracon SI; Drachman DA; Schneider LS; Whitehouse PJ; Hoover TM
N Engl J Med; 1992 Oct; 327(18):1253-9. PubMed ID: 1406817
[TBL] [Abstract][Full Text] [Related]
5. An enriched-population, double-blind, placebo-controlled, crossover study of tacrine and lecithin in Alzheimer's disease. The Tacrine 970-6 Study Group.
Foster NL; Petersen RC; Gracon SI; Lewis K
Dementia; 1996; 7(5):260-6. PubMed ID: 8872417
[TBL] [Abstract][Full Text] [Related]
6. Delayed matching-to-sample performance during a double-blind trial of tacrine (THA) and lecithin in patients with Alzheimer's disease.
Perryman KM; Fitten LJ
Life Sci; 1993; 53(6):479-86. PubMed ID: 8341134
[TBL] [Abstract][Full Text] [Related]
7. A controlled trial of tacrine in Alzheimer's disease. The Tacrine Study Group.
Farlow M; Gracon SI; Hershey LA; Lewis KW; Sadowsky CH; Dolan-Ureno J
JAMA; 1992 Nov; 268(18):2523-9. PubMed ID: 1404819
[TBL] [Abstract][Full Text] [Related]
8. Tetrahydroaminoacridine-lecithin combination treatment in patients with intermediate-stage Alzheimer's disease. Results of a Canadian double-blind, crossover, multicenter study.
Gauthier S; Bouchard R; Lamontagne A; Bailey P; Bergman H; Ratner J; Tesfaye Y; Saint-Martin M; Bacher Y; Carrier L
N Engl J Med; 1990 May; 322(18):1272-6. PubMed ID: 2183056
[TBL] [Abstract][Full Text] [Related]
9. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study Group.
Knapp MJ; Knopman DS; Solomon PR; Pendlebury WW; Davis CS; Gracon SI
JAMA; 1994 Apr; 271(13):985-91. PubMed ID: 8139083
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydroaminoacridine and lecithin in the treatment of Alzheimer's disease. Effect on cognition, functioning in daily life, behavioural disturbances and burden experienced by the carers.
Weinstein HC; Teunisse S; van Gool WA
J Neurol; 1991 Feb; 238(1):34-8. PubMed ID: 2030370
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the efficacy and safety of tetrahydroaminoacridine (THA) without lecithin in the treatment of Alzheimer's disease.
Wilcock GK; Surmon DJ; Scott M; Boyle M; Mulligan K; Neubauer KA; O'Neill D; Royston VH
Age Ageing; 1993 Sep; 22(5):316-24. PubMed ID: 8237620
[TBL] [Abstract][Full Text] [Related]
12. Velnacrine for the treatment of Alzheimer's disease: a double-blind, placebo-controlled trial. The Mentane Study Group.
Zemlan FP
J Neural Transm (Vienna); 1996; 103(8-9):1105-16. PubMed ID: 9013398
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of tacrine hydrochloride (Cognex) in two parallel-group studies.
Gracon SI
Acta Neurol Scand Suppl; 1996; 165():114-22. PubMed ID: 8740998
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness and safety of velnacrine for the treatment of Alzheimer's disease. A double-blind, placebo-controlled study. Mentane Study Group.
Antuono PG
Arch Intern Med; 1995 Sep; 155(16):1766-72. PubMed ID: 7654110
[TBL] [Abstract][Full Text] [Related]
15. A double-blind, placebo-controlled study of tacrine in Chinese patients with Alzheimer's disease.
Wong WJ; Liu HC; Fuh JL; Wang SJ; Hsu LC; Wang PN; Sheng WY
Dement Geriatr Cogn Disord; 1999; 10(4):289-94. PubMed ID: 10364647
[TBL] [Abstract][Full Text] [Related]
16. The effect of tacrine and lecithin in Alzheimer's disease. A population pharmacodynamic analysis of five clinical trials.
Holford NH; Peace K
Eur J Clin Pharmacol; 1994; 47(1):17-23. PubMed ID: 7988619
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Alzheimer's disease with short- and long-term oral THA and lecithin: a double-blind study.
Fitten LJ; Perryman KM; Gross PL; Fine H; Cummins J; Marshall C
Am J Psychiatry; 1990 Feb; 147(2):239-42. PubMed ID: 2405720
[TBL] [Abstract][Full Text] [Related]
18. Velnacrine for Alzheimer's disease.
Birks J; Wilcock GG
Cochrane Database Syst Rev; 2004; (2):CD004748. PubMed ID: 15106259
[TBL] [Abstract][Full Text] [Related]
19. Key methodological features of randomized controlled trials of Alzheimer's disease therapy. Minimal clinically important difference, sample size and trial duration.
Burback D; Molnar FJ; St John P; Man-Son-Hing M
Dement Geriatr Cogn Disord; 1999; 10(6):534-40. PubMed ID: 10559571
[TBL] [Abstract][Full Text] [Related]
20. Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG.
Minthon L; Gustafson L; Dalfelt G; Hagberg B; Nilsson K; Risberg J; Rosén I; Seiving B; Wendt PE
Dementia; 1993; 4(1):32-42. PubMed ID: 8358504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
